What the early studies can tell you
CJC-1295 raises growth hormone and IGF-1, a liver-made blood reading, but no health benefit is proved
This compound is a small, lab-made piece of protein. The page covers the blood-test changes, the safety gaps, and the two forms.
The chronology
What CJC-1295 changes in your blood
CJC-1295 is a small, lab-made piece of protein; it copies a body message from the brain that prompts your growth gland to release growth hormone. The natural message contains 29 protein parts.
Chemists changed parts 2, 8, 15, and 27, which slows how fast your body breaks the compound down [2][11]. Those part numbers don't tell you whether the compound helps or harms you. The long-acting form, called DAC, has an added binding part. That part joins albumin, the main carrying protein in your blood, and keeps the compound there longer [2][10].
One small, short study gave healthy adults a shot in the fatty layer beneath the skin. Researchers used 30 or 60 micrograms per kilo, with each microgram equal to one millionth of a gram. The study amount rose with each person's weight. Average growth hormone rose 2- to 10-fold, while IGF-1, a growth reading made mainly by the liver, stayed high for nine to eleven days [1]. The long-acting form took about 5.8 to 8.1 days to fall by half in your blood.
CJC-1295 hasn't been shown to treat an illness. The study found lasting blood-test changes, not better health or longer life. The study findings and amounts researchers used are on separate pages with the questions they left open. No agency has approved the compound as a treatment.
The names are easy to mix up. CJC-1295 DAC and no-DAC are the long-acting and short-acting forms. DAC means an added part binds to a blood protein, so that form lasts for days. The short form also goes by Modified GRF and leaves much sooner.
What the CJC-1295 peptide was made to do
The CJC-1295 peptide is not a steroid or a replacement hormone. A peptide is a small piece of protein. The long-acting form has four small changes that slow how fast your body clears it. It also binds to albumin, the main carrying protein in blood [2].
Lab records list the free form at about 3,368 daltons, a weight for things far too small to see. After the albumin bond forms, the pair weighs near 66 kilodaltons, meaning thousands of those tiny weight units. The bond adds the weight of albumin to the compound.
That larger pair can travel with albumin and remain in your blood longer. The weights don't show that the compound is safe or useful for you. Those questions need human studies that follow people for much longer.
What CJC-1295 does to growth hormone
CJC-1295 acts at your growth gland near the brain's base; there, the compound copies a message that prompts the gland to release growth hormone [1][3]. Growth hormone then tells the liver to raise IGF-1, another growth-related blood reading. These are the same steps your body uses on its own.
One small study followed healthy men. One amount raised their lowest growth-hormone reading about 7.5-fold. Their average reading was still about 46% higher one week later [3]. The normal rises and falls during each day remained.
These results show blood-test changes, not longer life, greater strength, or weight loss. The later program for long-acting CJC-1295 stopped. Public records don't say why or show that a safety finding caused the stop. Sports rules also ban CJC-1295 at all times [6].
The sports ban matters if you compete, even while the health effects remain unknown. The common CJC-1295 questions page covers both approval and sports rules. Neither point proves a health benefit.
What hasn't been shown in people
No study has shown that CJC-1295 helps people live longer. Growth hormone and IGF-1, a growth reading made mainly by the liver, tend to fall with age. Researchers have asked whether changing that fall might slow muscle loss in older adults [8]. The answer for your health is still unknown.
Related compounds gave only early clues. Some were studied for wound healing [9]. Other work looked at bone and skin in old mice [10]. Results in mice can't tell you what the compound will do.
Human studies of CJC-1295 were short and mainly watched blood tests. The long-acting program stopped, while newer reviews still call the compound an open question [13]. No sound answer exists yet about long-term help or harm.
Where to read more
Start with the CJC-1295 study results for the main facts. That page names the blood-test changes, the small groups, and the safety gaps. It also explains ipamorelin, a second compound that can prompt growth hormone release. No benefit to your health is promised.
Use CJC-1295 DAC versus no-DAC when a vial or page does not name the form clearly. The long form goes by DAC; Modified GRF (1-29) means the short form. CJC-1295 half life explains how long each stays. The research amounts page does not give you a personal plan.
Each number was checked against the paper on the references page. The people studied and the length of each study matter as much as any result. When a study leaves a question open, we say that plainly. A guess would not help you.
What to read before you weigh the risks
The Safety Notes page separates online stories from study findings; it names known risks and questions doctors still can't answer.